Search results
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance Canada· 2 months agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance Canada· 3 weeks agoFor Immediate Releases Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured...
FDA Panel Endorses AstraZeneca (AZN), Sanofi's RSV Antibody
Zacks via Yahoo Finance Canada· 1 year agoAstraZeneca AZN and Sanofi SNY announced that an FDA advisory committee recommended approving the...
‘Healthy’ doctor, 32, died after rare severe reaction to AstraZeneca Covid jab
PA Media: UK News via Yahoo Canada News· 1 year agoA “fit and healthy” doctor died from the “unintended consequences of vaccination” after a rare...
AstraZeneca claims allegations Covid jab is defective are ‘confused’ and ‘wrong in law’
The Telegraph via Yahoo Canada News· 8 months agoAstraZeneca said three billion doses of the vaccine had been supplied to 180 countries and saved...
AstraZeneca (AZN) Anticoagulant Drug Study Meets Efficacy Goal
Zacks via Yahoo Finance Canada· 1 year agoAt the interim analysis, AstraZeneca's (AZN) drug Andexxa showed superior hemostatic efficacy or in...
AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal
Zacks via Yahoo Finance Canada· 1 year agoInterim data from a late-stage study shows that AstraZeneca's (AZN) cancer drugs, Lynparza and...
AstraZeneca (AZN) Gets FDA CRL for Ultomiris in New Indication
Zacks via Yahoo Finance Canada· 11 months agoAstraZeneca AZN announced that the FDA has issued a complete response letter to its regulatory...
AstraZeneca asks the FDA to let adults give themselves the annual flu vaccine
Yahoo Finance· 9 months agoAstraZeneca (AZN) is asking the FDA to approve its nasal flu vaccine, FluMist, for use at home — a...
AstraZeneca (AZN) Gets EU Nod & CHMP Opinions for Some Drugs
Zacks via Yahoo Finance Canada· 2 years agoThe CHMP recommends approvals for expanded use of AstraZeneca's (AZN) Enhertu in breast cancer,...